Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome
about
Mediator kinase module and human tumorigenesisGenome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinomaCyclin H expression is increased in GIST with very-high risk of malignancyApproach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics.A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.Cyclin C is a haploinsufficient tumour suppressor.Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort studyPrognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.A novel function for Cyclin A2: control of cell invasion via RhoA signaling.Network Topologies Decoding Cervical Cancer.Expression of cyclin E in stage III colorectal carcinomaDifferences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.The cyclins: a family of widely expressed tumor antigens?Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1.Epigenetic modifications induced by RGC-32 in colon cancer.Morphologic and molecular events at the invading edge of colorectal carcinomas.Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells.Cell cycle regulation and anticancer drug discovery.Cyclin A2 Protein Overexpression Is Not Caused by Gene Amplification in Colon CancerThe atypical cyclin CNTD2 promotes colon cancer cell proliferation and migration
P2860
Q26800203-1AD2351B-7EA0-4132-BF2F-608BF92BB5A6Q28385454-B56FE73B-ABE2-491F-9155-FA39E1F453EAQ33624209-A99CAFBA-2E66-43E1-9105-AF25A989B01BQ34041422-D5499D82-B4D1-4276-9DDD-48EDFC5E07B9Q34066685-A41CDBE4-1A90-49D6-AF3C-16163A638551Q34444847-0A41A16F-3738-4BBD-9999-E171D4BEBBB9Q35146690-871381CA-9970-422A-935C-ADBD71D4DCA7Q35151182-D226C86E-B8FE-4B9D-B4F8-059B8B96380AQ35231140-C569D5BA-F201-45CF-BC03-4C1153EE6E97Q35550222-EB8253E6-0459-4F0C-8BDD-8201480B8A23Q35666323-FA851C7D-19E1-41DB-8AE3-81FEE26B26CAQ35756027-F40AF009-3D09-4F36-BA88-A13E9B936E7FQ36475933-30BBDBCA-A6C4-4CE6-A734-CC670CC43FE7Q37484830-A93EA75C-1FE1-4E75-9504-38FC10A79E88Q37857261-FBDC39EE-CF22-456D-9C8B-B4234C6DA923Q38369468-D86E6F3F-4663-4C8D-B126-88696E9A70E4Q39559509-BD915F22-8508-467B-B9EF-59420C07F991Q39780293-A321760C-249E-4906-BE97-193576DB68D3Q40795997-A183B5F1-50F3-493B-8918-367706E57C78Q47101574-4E2A9DE8-4EF1-49C3-8235-23CCCCC20723Q49449591-A0C1C69F-FAF7-4C43-BCFB-6757980BCFA3Q58692130-F4732EB1-C9F2-4A52-B881-2B0E5A74AB4FQ58797903-64FC9458-FD1B-4CD0-821F-FC5F7C765FCC
P2860
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression and gene amplificat ...... rrelation with patient outcome
@ast
Expression and gene amplificat ...... rrelation with patient outcome
@en
type
label
Expression and gene amplificat ...... rrelation with patient outcome
@ast
Expression and gene amplificat ...... rrelation with patient outcome
@en
prefLabel
Expression and gene amplificat ...... rrelation with patient outcome
@ast
Expression and gene amplificat ...... rrelation with patient outcome
@en
P2093
P2860
P356
P1476
Expression and gene amplificat ...... rrelation with patient outcome
@en
P2093
P2860
P304
P356
10.1136/JCP.2004.020347
P407
P577
2005-05-01T00:00:00Z